Ana B Pavel Selected Research

Ana B Pavel Research Topics

Disease

25	Atopic Dermatitis (Atopic Eczema) 01/2023 - 01/2018
10	Alopecia Areata 01/2023 - 11/2018
9	Inflammation (Inflammations) 01/2023 - 10/2019
6	Neoplasms (Cancer) 01/2023 - 02/2016
5	Hyperplasia 01/2023 - 01/2018
5	Alopecia (Baldness) 10/2022 - 01/2021
4	Skin Diseases (Skin Disease) 01/2023 - 01/2019
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2019
4	Atherosclerosis 10/2021 - 01/2020
3	Vitiligo 03/2023 - 01/2019
3	COVID-19 01/2022 - 01/2021
3	Pruritus (Itching) 11/2019 - 01/2019
2	Ichthyosis (Xeroderma) 03/2023 - 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2023
1	Infections 03/2023
1	Mycoses (Diseases, Fungus) 03/2023
1	Hypersensitivity (Allergy) 01/2023
1	Lamellar Ichthyosis (Harlequin Ichthyosis) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Congenital Ichthyosiform Erythroderma 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Netherton Syndrome 01/2022
1	Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma) 01/2022
1	Melanoma (Melanoma, Malignant) 12/2021
1	Actinic Keratosis 12/2021
1	Skin Neoplasms (Skin Cancer) 12/2021
1	Eczema 10/2021
1	Granuloma Annulare 07/2020
1	Keloid 01/2020
1	Headache (Headaches) 01/2019
1	Diarrhea 01/2019
1	Nasopharyngitis 01/2019
1	Nausea 01/2019
1	Lung Neoplasms (Lung Cancer) 11/2017

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
10	dupilumabIBA 01/2023 - 01/2020
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
6	RNA (Ribonucleic Acid)IBA 11/2023 - 11/2017
5	SaltsIBA 10/2022 - 01/2021
4	Interleukin-17 (Interleukin 17)IBA 03/2023 - 01/2019
4	Janus KinasesIBA 01/2022 - 10/2019
4	CytokinesIBA 01/2021 - 01/2019
3	apremilastIBA 03/2023 - 01/2019
3	InterleukinsIBA 01/2023 - 01/2019
3	fezakinumabIBA 01/2022 - 01/2018
3	Interleukin-22 (IL-22)IBA 01/2019 - 01/2018
2	MicroRNAs (MicroRNA)IBA 11/2023 - 11/2017
2	secukinumabIBA 03/2023 - 01/2021
2	LipidsIBA 01/2023 - 01/2021
2	crisaboroleIBA 01/2023 - 11/2019
2	ProteomeIBA 01/2023 - 01/2023
2	Monoclonal AntibodiesIBA 01/2022 - 01/2018
2	Janus Kinase InhibitorsIBA 01/2022 - 01/2021
2	Interleukin-13IBA 01/2021 - 01/2019
2	Keratin-16 (Keratin 16)IBA 01/2019 - 01/2019
1	Protein Isoforms (Isoforms)IBA 11/2023
1	ElafinIBA 01/2023
1	AllergensIBA 01/2023
1	NickelIBA 01/2023
1	diphenylcyclopropenoneIBA 01/2023
1	Tuberculin (PPD)IBA 01/2023
1	Tec protein-tyrosine kinaseIBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2022
1	Transforming Growth Factor beta3 (TGF beta 3)IBA 01/2022
1	ArsenicIBA 12/2021
1	ChromiumIBA 12/2021
1	Heavy MetalsIBA 12/2021
1	interleukin-21 (interleukin 21)IBA 10/2021
1	silk elastin-like protein (SELP)IBA 02/2021
1	4- (cyclopropylamino)- 2- ((4- (4- (ethylsulfonyl)piperazin- 1- yl)phenyl)amino)pyrimidine- 5- carboxamideIBA 01/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021
1	fibroblast growth factor 21IBA 01/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2020
1	S100A12 ProteinIBA 01/2020
1	Kallikreins (Kallikrein)IBA 01/2020
1	E-SelectinIBA 01/2020
1	chitotriosidaseIBA 01/2020
1	ChemokinesIBA 01/2020
1	Ointments (Pastes)IBA 11/2019
1	Phosphodiesterase 4 InhibitorsIBA 11/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 11/2019
1	gusacitinibIBA 10/2019
1	6-sulfo sialyl Lewis XIBA 01/2019
1	loricrinIBA 01/2019
1	Filaggrin ProteinsIBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	Interleukin-9 (Interleukin 9)IBA 01/2019
1	Messenger RNA (mRNA)IBA 11/2017
1	AlpelisibIBA 02/2016
1	PLX 4720IBA 02/2016
1	AZD 6244IBA 02/2016
1	nutlin 3IBA 02/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2016

Therapy/Procedure

4	Therapeutics 03/2023 - 12/2016
3	Aftercare (After-Treatment) 10/2022 - 01/2020